Pfizer said a Phase 2 study of tilrekimig met its key goals in adults with moderate to severe atopic dermatitis, the most common form of eczema, and that it plans to accelerate the drug candidate into ...

Nearly 40% of eczema patients and caregivers surveyed by the National Eczema Association (NEA) reported at least one ...

Pfizer said on Monday its experimental drug for ‌a chronic skin disease met the ‌main goal in a mid-stage study. Here are ...

"This product is really nice. its brill for little hands and kind to your skin. My son who suffers from eczema uses this with no problems and I will be buying more when on offer again." ...

Pfizer Inc (NYSE:PFE) shares declined 1.15% to $26.74 in premarket trading Monday, even after the pharmaceutical company ...

Declining estrogen levels can lead to skin barrier dysfunction and eczema flares during menopause. Learn about skin-care adjustments, medical treatments, and the role of menopausal hormone therapy.

While misinformation continues to appear on online platforms, like Reddit, community engagement tends to favor discussions ...

ZORYVE cream 0.05% was safe and well-tolerated, with efficacy that was maintained and improved over time up to 56 weeks of treatmentChildren ages ...

Chronic Hand Eczema (CHE) is a highly debilitating inflammatory skin disease that affects approximately one in ten adults in the U.S. 1. ANZUPGO ® (delgocitinib) cream is the fir ...

Many clinical-stage biotech stocks have the potential to surge by more than 1,000% if they successfully make the transition to the commercial stage with approved and well-received therapies. But small ...

Many eczema patients skip the mental health talk. Learn how to discuss anxiety and depression with your dermatologist to unlock better treatment options and systemic therapies.

The campaign focuses on educating the one in 10 U.S. adults living with chronic hand eczema (CHE), particularly the one in three patients who have never heard the specific name of their condition.